Stay updated on Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page
- Check6 days agoChange DetectedAn NIH grant/contract attribution for 2016 was added to the study's identifiers. This documents the funding source supporting the trial.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4 on the page, representing a small update to the page's revision metadata.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This indicates a minor update to the page's metadata or documentation rather than changes to the study content displayed to users.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, signaling a new deployment. This update does not modify the study details or other content visible to users.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows recruitment is closed, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added; the Intervention/Treatment heading formatting was updated and the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page footer's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page’s revision history.SummaryDifference0.0%

Stay in the know with updates to Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.